AzTrials
AzTrials

Tooth ExtractionNCT07044895

Diode Laser Photocoagulation With Immediate Implant Placement

A study testing Diode laser and Immediate implant in people with Tooth Extraction and Immediate Dental Implant, run by Hams Hamed Abdelrahman at 1 site in Lebanon.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Placement of an immediate implant is becoming popular because of its potential in minimizing the treatment time and enhancing the patient comfort and esthetic outcomes. It is crucial to maintain adequate thickness of labial bone with the establishment of a stable and healthy gingival seal around the implant abutment… Read more about this study

Who is it for?
Ages 18 to 40 years
What is being tested?
Diode laser and Immediate implant
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8 participants
Where
1 siteLebanon
Study dates
30 Jun 2025to 25 Feb 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients with non-restorable maxillary teeth in the aesthetic zone are indicated for extraction and subsequent immediate implant placement, including those with:
  • A severely carious tooth that cannot be restored.
  • Pulpal necrosis or irreversible pulpitis that is not amenable to endodontics.
  • Periodontally involved teeth with grade 2 mobility or above.
  • Teeth with root caries that can't be restored.
  • Patients with an extraction socket Type I.
  • A good standard of oral hygiene.

Who cannot join

  • Patients with extraction socket Type II or III, with buccal plate defects.
  • Absence of at least 2 mm of bone apical to the extraction socket
  • tooth ankylosis.
  • Patients with deciduous teeth.
  • Heavy smokers.
  • Systemic conditions
  • History of oral or intravenous bisphosphonate therapy or any treatments with other medications that may interfere with bone metabolism within the past 12 months

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Lebanon1 site
  • Faculty of Dentistry clinics, Beirut Arab University

    Beirut

    Amina R Ali, BDS

    Amina R Ali, BDS

Other trials in Lebanon

About this study

Official title: Evaluation of Diode Laser Photocoagulation With Immediate Implant Placement in the Maxillary Esthetic Zone

Placement of an immediate implant is becoming popular because of its potential in minimizing the treatment time and enhancing the patient comfort and esthetic outcomes. It is crucial to maintain adequate thickness of labial bone with the establishment of a stable and healthy gingival seal around the implant abutment to prevent the invasion of bacteria and peri-implant inflammation. Diode lasers have been developed as a promising tool in dentistry, providing a precise manipulation and photocoagulation effect that may have a positive influence on both bone remodeling and soft tissue healing. This study aims to evaluate the effectiveness of the utilization of diode laser photocoagulation with immediate implant placement and customized healing abutment in the maxillary esthetic zone.

Being tested
Diode laser and Immediate implant

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diode laser and Immediate implantOther

    patients with non-restorable teeth in the maxillary esthetic zone will be included in this prospective single-arm study. The non-restorable tooth will be atraumatically extracted and immediate implant placement will be placed. The extraction socket will be sealed with diode laser photocoagulation and customized healing abutments fabrication.

Study groups in NCT07044895
Study groupRoleWhat they receive
Immediate implant with photocoagulationExperimentalNot described
Receives: Other: Diode laser and Immediate implant

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in pain socres

    Pain will be evaluated, using visual analogue scale (VAS) as follows:

    (0-1= None, 2-4= Mild, 5-7= Moderate, 8-10= Severe)

    Measured: at 7, 14, and 21 days

  2. Change in wound healing

    The wound healing will be assessed based on Landry Wound Healing Index. The Landry Index uses a numerical score based on the assessment of four given parameters (Erythema, Edema, Wound Margin Adaptation, and Presence of Exudate). Each parameter is given a score depending on its severity, and the total score determine an overall evaluation of wound healing

    Measured: at 7, 14, and 21 days

  3. Change in implant stability

    The base line primary Implant Stability Quotient (ISQ) will be measured during the operative stage, while the secondary stability quotient will be measured 6-months post-operative during the prosthetic phase preparation.

    Measured: baseline and 6 months

Secondary outcomes (3)
  1. Change in Crestal Alveolar Process width

    The width of the crestal alveolar process will be assessed by determination of the dimensional changes of Bucco-palatal ridge in the 6 months' scan

    Measured: baseline and 6 months

  2. Change in labial bone thickness

    The overall persistence of the labial plate of bone after the atraumatic extraction and immediate implant placement will be evaluated by the assessment of the thickness labial plate of bone in the scan performed after 6 months and comparing it with the preoperative CBCT record. The distance will be measured from the root surface to the outer buccal bone surface in the preoperative CBCT record. Measurements will be performed on the cross-sectional cut of the CBCT at three levels; crestal labial thickness, middle labial thickness, and apical labial thickness.

    Measured: baseline and 6 months

  3. Change in esthetic of soft tissue

    The pink esthetic score (PES) introduced by Furhauser et al will be used for evaluation of the esthetic outcome of soft tissue surrounding single crowns supported by implant in the esthetic zone. The PES consists of seven factors each one is given a score of 2, 1, or 0, and a total score will be ranging between 0 and 14

    Measured: at 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2025
  2. Study start30 Jun 2025 (estimated)
  3. Primary completion25 Feb 2026 (estimated)
  4. Study completion25 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
8 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07044895
Sponsor's protocol ID
2025-H-0167-D-M-0754
Status last verified
Jun 2025
First submitted
22 Jun 2025
Last updated
1 Jul 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Diode laser and Immediate implant in people with Tooth Extraction and Immediate Dental Implant, run by Hams Hamed Abdelrahman at 1 site in Lebanon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 1 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Lebanon. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Amina R Ali, BDS (+961 70 908 487, dr_aminahweidi2016@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in pain socres (time frame: at 7, 14, and 21 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2025; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in